Filtrona well positioned for further growth

Speciality plastic, fibre and foam products supplier Filtrona said it is well positioned to deliver growth for the full year as it reported a 24 per cent increase in half year revenue.

Revenue at constant FX grew to £324.8m for the half year ended 30 June 2012 from £268.6m the same time a year earlier. Like for like revenue increased 9% after progress at all its major divisions.

Pre-tax profit rose to £40.8m from £37.8m in the same period last year. Adjusted operating profit rose 26% while adjusted operating margin grew 30bps to 16.7%.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

"Given this performance, Filtrona remains well-positioned to deliver further balanced growth in 2012," said chief executive Colin Day.

Net debt rose to £183m from £145m previously, after the £36m acquisition spend on Lymtech Scientific, Jae Yong and Securit.

Filtrona raised its first-half dividend by 18% to 3.9p per share.

As at June 30, the group's gross pension liability was £27.1m, up from £12.7m a year earlier.

CJ